Have a feature idea you'd love to see implemented?
Let us know!
SNSE Sensei Biotherapeutics Inc
Price (delayed)
$0.484
Market cap
$12.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.19
Enterprise value
-$2.49M
Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed
Highlights
SNSE's debt is down by 34% YoY and by 11% from the previous quarter
The net income has increased by 23% year-on-year
SNSE's equity is down by 36% YoY and by 12% from the previous quarter
The quick ratio is down by 25% YoY and by 18% from the previous quarter
Key stats
What are the main financial stats of SNSE
Market
Valuations
Earnings
Shares outstanding
25.15M
Market cap
$12.17M
Enterprise value
-$2.49M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.27
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$29.7M
EBITDA
-$26.86M
Free cash flow
-$25.19M
Per share
Balance sheet
Liquidity
EPS
-$1.19
Free cash flow per share
-$1
Book value per share
$1.82
Revenue per share
$0
TBVPS
$2.12
Total assets
$53.25M
Total liabilities
$7.48M
Debt
$4.47M
Equity
$45.78M
Working capital
$42.66M
Debt to equity
0.1
Current ratio
8.84
Quick ratio
8.64
Net debt/EBITDA
0.55
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-46.9%
Return on equity
-53.9%
Return on invested capital
-59.6%
Return on capital employed
-62.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNSE stock price
How has the Sensei Biotherapeutics stock price performed over time
Intraday
-2.81%
1 week
4.74%
1 month
-37.95%
1 year
-26.64%
YTD
-30.06%
QTD
-19.06%
Financial performance
How have Sensei Biotherapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.48M
Net income
-$29.8M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 23% YoY
The net income has increased by 23% year-on-year
Growth
What is Sensei Biotherapeutics's growth rate over time
Valuation
What is Sensei Biotherapeutics stock price valuation
P/E
N/A
P/B
0.27
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
SNSE's EPS is up by 10% year-on-year
SNSE's equity is down by 36% YoY and by 12% from the previous quarter
The price to book (P/B) is 10% lower than the last 4 quarters average of 0.3
Efficiency
How efficient is Sensei Biotherapeutics business performance
The ROIC fell by 34% YoY and by 20% QoQ
SNSE's ROE is down by 21% YoY and by 12% from the previous quarter
The company's return on assets fell by 20% YoY and by 12% QoQ
Dividends
What is SNSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNSE.
Financial health
How did Sensei Biotherapeutics financials performed over time
Sensei Biotherapeutics's total assets has decreased by 35% YoY and by 11% from the previous quarter
Sensei Biotherapeutics's total liabilities has decreased by 30% YoY
SNSE's debt is 90% less than its equity
SNSE's equity is down by 36% YoY and by 12% from the previous quarter
SNSE's debt is down by 34% YoY and by 11% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.